FIBROBLAST GROWTH FACTOR 21 POTENTLY REDUCES ATHEROSCLEROSIS AND NASH DEVELOPMENT

被引：0

作者：

Liu, C. ^{[1
,2
]}

Schonke, M. ^{[1
,2
]}

Spoorenberg, B. ^{[1
,2
]}

Lambooij, J. ^{[3
,4
]}

Hendrik, V. D. Z. ^{[3
]}

Zhou, E. ^{[1
,2
]}

Dekker, N. ^{[5
]}

Andreasson, A-C ^{[6
]}

Park, A. ^{[7
]}

Uhrbom, M. ^{[6
]}

Ahlstedt, I. ^{[6
]}

Ikeda, Y. ^{[7
]}

Wallenius, K. ^{[6
]}

Peng, X-R ^{[6
]}

Guigas, B. ^{[3
]}

Boon, M. ^{[1
,2
]}

Wang, Y. ^{[1
,2
]}

Rensen, P. ^{[1
,2
]}

机构：

[1] Leiden Univ, Dept Med, Med Ctr, Leiden, Netherlands

[2] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands

[3] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands

[4] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands

[5] AstraZeneca BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden

[6] AstraZeneca, BioPharmaceut R&D, Biosci Metab Res & Early Dev Cardiovascr Renal &, Gothenburg, Sweden

[7] AstraZeneca, Oncol R&D, Biol Engn & Targeted Delivery, Gaithersburg, MD USA

来源：

ATHEROSCLEROSIS | 2022年 / 355卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SE123

引用

页码：E74 / E75

页数：2

共 50 条

[41] Potential roles of fibroblast growth factor 21 in the brain
Piangkwan Sa-nguanmoo
Nipon Chattipakorn
Siriporn C. Chattipakorn
Metabolic Brain Disease, 2016, 31 : 239 - 248
[42] Therapeutic effects of fibroblast growth factor-21 against atherosclerosis via the NF-B pathway
Zhang, Yiming
Liu, Zhao
Zhou, Min
Liu, Changjian
MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 1453 - 1460
[43] The Role of Fibroblast Growth Factor 21 (FGF21) in the Pancreas
Singhal, Garima
Fisher, Ffolliott Martin
El Ouaamari, Abdelfattah
Kulkarni, Rohit N.
Flier, Jeffery S.
Flier, Eleftheria Maratos
DIABETES, 2014, 63 : A559 - A559
[44] Fibroblast growth factor 21: from pharmacology to physiology
Kliewer, Steven A.
Mangelsdorf, David J.
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (01): : 254S - 257S
[45] Potential roles of fibroblast growth factor 21 in the brain
Sa-nguanmoo, Piangkwan
Chattipakorn, Nipon
Chattipakorn, Siriporn C.
METABOLIC BRAIN DISEASE, 2016, 31 (02) : 239 - 248
[46] Fibroblast growth factor 21 in chronic kidney disease
Anuwatmatee, Sahapab
Tang, Shudi
Wu, Ben J.
Rye, Kerry-Anne
Ong, Kwok Leung
CLINICA CHIMICA ACTA, 2019, 489 : 196 - 202
[47] Fibroblast Growth Factor 21 Signaling: The Liver in Focus
Mahlapuu, Margit
Marschall, Hanns-Ulrich
HEPATOLOGY, 2016, 64 (02) : 333 - 335
[48] Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
She, Qin-Ying
Bao, Jing-Fu
Wang, Hui-Zhen
Liang, Huixin
Huang, Wentao
Wu, Jing
Zhong, Yiwen
Ling, Hanxin
Li, Aiqing
Qin, Shu-Lan
METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 130
[49] Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, Tamer
Bina, Holly A.
Schneider, Michael A.
Dunbar, James D.
Hu, Charlie C.
Chen, Yanyun
Moller, David E.
Kharitonenkov, Alexei
ENDOCRINOLOGY, 2008, 149 (12) : 6018 - 6027
[50] Fibroblast growth factor 21 in chronic kidney disease
de Albuquerque Suassuna, Paulo Giovanni
de Paula, Rogerio Baumgratz
Sanders-Pinheiro, Helady
Moe, Orson W.
Hu, Ming-Chang
JOURNAL OF NEPHROLOGY, 2019, 32 (03) : 365 - 377

← 1 2 3 4 5 →